Multigene Kinase Network, Kidney Transport and Salt in Essential Hypertension
Multigene Kinase Network, Kidney Transport and Salt in Essential Hypertension
批准号:
7938618
负责人:
Paul A Welling
金额:
$49.99万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-25 至 2012-07-31
关键词:
AffectAldosteroneAllelesAnimal ModelAntibodiesBlood PressureCardiovascular systemCarrier ProteinsCellsComplexDevelopmentDietary SodiumDiseaseDistalEnd stage renal failureEssential HypertensionExcretory functionFamilial diseaseGeneral PopulationGenesGenetic PolymorphismGenetic Predisposition to DiseaseHeart failureHumanHypertensionInterventionKidneyKnowledgeLightMineralocorticoidsModelingMolecular GeneticsMorbidity - disease rateMusMutateMutationMyocardial InfarctionNephronsPathway interactionsPhenotypePhosphorylationPhosphotransferasesPhysiologicalPlanetsPotassiumPredispositionProtein-Serine-Threonine KinasesPublic HealthReagentRegulationRenal functionSignal TransductionSodiumSodium ChlorideStressStrokeSusceptibility GeneSystemTestingThiazide DiureticsTransgenic AnimalsTransgenic MiceVariantWorkgene environment interactiongenome wide association studyhyperkalemiamortalitymouse modelnovelnovel therapeuticspublic health relevanceresponsesalt balancesymportertool
中文摘要
描述(申请人提供):原发性高血压是对公众健康的主要威胁,影响着世界上超过10亿人,并导致每年500万人的肾脏和心血管疾病死亡和发病率。与其他复杂的疾病一样,具有不同等位基因的多个基因和不同的环境压力被认为是导致这种疾病的原因。利用全基因组关联策略,我们最近发现了第一个高血压易感基因STK39(又名Spak丝氨酸/苏氨酸激酶),阐明了一个新描述的多基因激酶网络和一种特殊的环境触发因素--饮食盐--在高血压的发生中。来自我们团队和其他人的现有证据表明:1)STK39与WNK基因的产物,即在一种罕见的高血压和高钾血症家族性疾病中突变的丝氨酸/苏氨酸激酶相互作用,控制肾盐的排泄和维持血压;2)饮食中的钠和钾以不同的方式通过STK39/WNK途径触发信号,调节关键的肾盐转运蛋白-噻嗪利尿剂敏感的氯化钠转运体(NCC)的活性;3)-STK39信号的异常获得导致NCC活性的不适当增加,导致钠滞留和高血压。在这里,我们聚集了一个多学科的团队,以我们最近的发现为基础,开发和应用新的转基因动物模型和试剂来测试这些关于基因-基因和基因-环境相互作用在高血压发展中的令人兴奋的新想法。这些新工具和知识的开发将揭示这种疾病的潜在分子和遗传机制。它还将提供急需的模型,以研究和确定新的干预治疗策略。
公共卫生相关性:原发性高血压是对公共健康的重大威胁,影响着世界上10多亿人,并导致每年500万人的肾脏和心血管疾病死亡和发病率。与其他复杂的疾病一样,具有不同等位基因的多个基因和不同的环境压力被认为是导致这种疾病的原因。在这里,我们聚集了该领域的多学科专家团队,开发和应用新的转基因动物模型和试剂,以测试关于多激酶基因网络和特定环境触发因素--食盐--在高血压发生中的令人兴奋的新想法,基于我们最近在GWA发现的STK39激酶作为一种基本的高血压易感基因。
英文摘要
DESCRIPTION (provided by applicant): Essential hypertension is a major threat to public health, affecting over a billion people in the world and contributing to kidney and cardiovascular mortality and morbidity in 5 million people annually. Like other complex disorders, multiple genes with variant alleles and different environmental stresses are thought to contribute to the disease. Using a genome-wide association strategy, we recently identified the first essential hypertension susceptibility gene, STK39 (aka SPAK serine/threonine kinase), illuminating a newly described, multi-gene kinase network and a specific environmental trigger--dietary salt-- in the genesis of hypertension. Available evidence from our group and others suggests: 1) STK39 interacts with the products of the WNK genes, serine/threonine kinases that are mutated in a rare familial disorder of hypertension and hyperkalemia, to control kidney salt excretion and maintain blood pressure; 2) Dietary sodium and potassium differently trigger signaling through the STK39/WNK pathway to regulate the activity of a key renal salt transport protein, the thiazide diuretic sensitive sodium chloride co- transporter (NCC); 3) Aberrant gain-of-STK39 signaling causes an inappropriate increase in NCC activity, leading to sodium retention and hypertension. Here we bring together a mutlidisciplinary team to develop and apply novel transgenic animal models and reagents to test these exciting new ideas about gene-gene and gene-environment interactions in the development of hypertension, building on our recent discoveries. Development of these new tools and knowledge will shed light on the underlying molecular and genetic mechanisms of the disease. It also will provide much-needed models to study and identify new therapeutic strategies for intervention.
PUBLIC HEALTH RELEVANCE: Essential hypertension is a major threat to public health, affecting over a billion people in the world and contributing to kidney and cardiovascular mortality and morbidity in 5 million people annually. Like other complex disorders, multiple genes with variant alleles and different environmental stresses are thought to contribute to the disease. Here we bring together a mutlidisciplinary team of experts in the field to develop and apply novel transgenic animal models and reagents to test exciting new ideas about a multi-kinase gene network and a specific environmental trigger--dietary salt--in the genesis of hypertension, building on our recent GWA discovery of STK39 kinase as an essential hypertension susceptibility gene.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biomedical Resource Core
-
批准号:10747705
-
项目类别:
-
资助金额:$28.59万
-
财政年份:2023
-
负责人:Paul A Welling
-
依托单位:
Molecular Mechanism of ROMK Channel Function
-
批准号:9897412
-
项目类别:
-
资助金额:$50.62万
-
财政年份:2019
-
负责人:Paul A Welling
-
依托单位:
Molecular Mechanism of ROMK Channel Function
-
批准号:10048980
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2019
-
负责人:Paul A Welling
-
依托单位:
Polarized Trafficking of K+ Channels in the Kidney
-
批准号:7913908
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2009
-
负责人:Paul A Welling
-
依托单位:
Multigene Kinase Network, Kidney Transport and Salt in Essential Hypertension
-
批准号:7820603
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:Paul A Welling
-
依托单位:
Molecular Basis of Potassium Channels in the Kidney
-
批准号:8438676
-
项目类别:
-
资助金额:$33.39万
-
财政年份:2003
-
负责人:Paul A Welling
-
依托单位:
Polarized Trafficking of K+ Channels in the Kidney
-
批准号:7171560
-
项目类别:
-
资助金额:$33.09万
-
财政年份:2003
-
负责人:Paul A Welling
-
依托单位:
Molecular Basis of Potassium Channels in the Kidney
-
批准号:8882403
-
项目类别:
-
资助金额:$33.39万
-
财政年份:2003
-
负责人:Paul A Welling
-
依托单位:
Polarized Trafficking of K+ Channels in the Kidney
-
批准号:6835681
-
项目类别:
-
资助金额:$34.9万
-
财政年份:2003
-
负责人:Paul A Welling
-
依托单位:
Polarized Trafficking of K+ Channels in the Kidney
-
批准号:6693785
-
项目类别:
-
资助金额:$34.9万
-
财政年份:2003
-
负责人:Paul A Welling
-
依托单位:
Polarized Trafficking of K+ Channels in the Kidney
-
批准号:6560533
-
项目类别:
-
资助金额:$34.9万
-
财政年份:2003
-
负责人:Paul A Welling
-
依托单位:
Polarized Trafficking of K+ Channels in the Kidney
-
批准号:7770890
-
项目类别:
-
资助金额:$31.56万
-
财政年份:2003
-
负责人:Paul A Welling
-
依托单位:
Polarized Trafficking of K+ Channels in the Kidney
-
批准号:7370807
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2003
-
负责人:Paul A Welling
-
依托单位:
Polarized Trafficking of K+ Channels in the Kidney
-
批准号:8042682
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2003
-
负责人:Paul A Welling
-
依托单位:
Molecular Basis of Potassium Channels in the Kidney
-
批准号:9100750
-
项目类别:
-
资助金额:$33.39万
-
财政年份:2003
-
负责人:Paul A Welling
-
依托单位:
Polarized Trafficking of K+ Channels in the Kidney
-
批准号:7000368
-
项目类别:
-
资助金额:$34.08万
-
财政年份:2003
-
负责人:Paul A Welling
-
依托单位:
Molecular Basis of Potassium Channels in the Kidney
-
批准号:8546331
-
项目类别:
-
资助金额:$32.22万
-
财政年份:2003
-
负责人:Paul A Welling
-
依托单位:
Molecular Basis of Potassium Channels in the Kidney
-
批准号:8708037
-
项目类别:
-
资助金额:$33.39万
-
财政年份:2003
-
负责人:Paul A Welling
-
依托单位:
Polarized Trafficking of K+ Channels in the Kidney
-
批准号:7568916
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2003
-
负责人:Paul A Welling
-
依托单位:
MOLECULAR MECHANISMS OF KIDNEY KATP CHANNEL FUNCTION
-
批准号:6358684
-
项目类别:
-
资助金额:$5.2万
-
财政年份:1998
-
负责人:Paul A Welling
-
依托单位:
海外基金